|
1
|
D'souza S and Addepalli V: Preventive
measures in oral cancer: An overview. Biomed Pharmacother.
107:72–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang X, Wu H and Ling T: Suppressive
effect of microRNA-126 on oral squamous cell carcinoma in
vitro. Mol Med Rep. 10:125–130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Callaghan K, Palagano E, Butini S,
Campiani G, Williams DC, Zisterer DM and O'Sullivan J: Induction of
apoptosis in oral squamous carcinoma cells by
pyrrolo-1,5-benzoxazepines. Mol Med Rep. 12:3748–3754. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang H, Wu Z, Zhang J and Su B: Salivary
lncRNA as a potential marker for oral squamous cell carcinoma
diagnosis. Mol Med Rep. 7:761–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye X, Wang X, Lu R, Zhang J, Chen X and
Zhou G: CD47 as a potential prognostic marker for oral leukoplakia
and oral squamous cell carcinoma. Oncol Lett. 15:9075–9080.
2018.PubMed/NCBI
|
|
6
|
Jeon JH, Kim MG, Park JY, Lee JH, Kim MJ,
Myoung H and Choi SW: Analysis of the outcome of young age tongue
squamous cell carcinoma. Maxillofac Plast Reconstr Surg. 39:412017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fu X, Chen S, Chen W, Yang Z, Song M, Li
H, Zhang H, Yao F, Su X, Liu T and Yang AK: Clinical analysis of
second primary gingival squamous cell carcinoma after radiotherapy.
Oral Oncol. 84:20–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bachar G, Hod R, Goldstein DP, Irish JC,
Gullane PJ, Brown D, Gilbert RW, Hadar T, Feinmesser R and Shpitzer
T: Outcome of oral tongue squamous cell carcinoma in patients with
and without known risk factors. Oral Oncol. 47:45–50. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vered M, Dayan D, Dobriyan A, Yahalom R,
Shalmon B, Barshack I, Bedrin L, Talmi YP and Taicher S: Oral
tongue squamous cell carcinoma: Recurrent disease is associated
with histopathologic risk score and young age. J Cancer Res Clin
Oncol. 136:1039–1048. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Farquhar DR, Tanner AM, Masood MM, Patel
SR, Hackman TG, Olshan AF, Mazul AL and Zevallos JP: Oral tongue
carcinoma among young patients: An analysis of risk factors and
survival. Oral Oncol. 84:7–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sgaramella N, Gu X, Boldrup L, Coates PJ,
Fahraeus R, Califano L, Tartaro G, Colella G, Spaak LN, Strom A, et
al: Searching for new Targets and Treatments in the battle against
squamous cell carcinoma of the head and neck, with specific focus
on tumours of the tongue. Curr Top Med Chem. 18:214–218. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Wu Z, Fu X and Han W: lncRNAs:
Insights into their function and mechanics in underlying disorders.
Mutat Res Rev Mutat Res. 762:1–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu X and Li Z: Long non-coding RNA HOTAIR:
A novel oncogene (Review). Mol Med Rep. 12:5611–5618. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Zhang R and Ying K: Long non-coding
RNAs: Novel links in respiratory diseases (Review). Mol Med Rep.
11:4025–4031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alvarez-Dominguez JR, Hu W, Gromatzky AA
and Lodish HF: Long noncoding RNAs during normal and malignant
hematopoiesis. Int J Hematol. 99:531–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Peng WX, Mo YY and Luo D:
MALAT1-mediated tumorigenesis. Front Biosci (Landmark Ed).
22:66–80. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu X, Li Z, Zheng H, Chan MT and Wu WK:
NEAT1: A novel cancer-related long non-coding RNA. Cell Prolif.
502017.doi: 10.1111/cpr.12329.
|
|
21
|
Hu XL, Wang J, He W, Zhao P and Wu WQ:
Down-regulation of lncRNA Linc00152 suppressed cell viability,
invasion, migration, and epithelial to mesenchymal transition, and
reversed chemo-resistance in breast cancer cells. Eur Rev Med
Pharmacol Sci. 22:3074–3084. 2018.PubMed/NCBI
|
|
22
|
Chen X, Li D, Gao Y, Tang W, Iw L, Cao Y
and Hao B: Long intergenic noncoding RNA 00152 promotes glioma cell
proliferation and invasion by interacting with miR-16. Cell Physiol
Biochem. 46:1055–1064. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J, Yin M, Huang J, Lv Z, Liang S,
Miao X, Huang F and Zhao Y: Long noncoding RNA LINC00152 as a novel
predictor of lymph node metastasis and survival in human cancer: A
systematic review and meta-analysis. Clin Chim Acta. 483:25–32.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haque SU, Niu L, Kuhnell D, Hendershot J,
Biesiada J, Niu W, Hagan MC, Kelsey KT, Casper KA, Wise-Draper TM,
et al: Differential expression and prognostic value of long
non-coding RNA in HPV-negative head and neck squamous cell
carcinoma. Head Neck. 40:1555–1564. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu J, Liu Y, Guo C, Zhang S, Gong Z, Tang
Y, Yang L, He Y, Lian Y, Li X, et al: Upregulated long non-coding
RNA LINC00152 expression is associated with progression and poor
prognosis of tongue squamous cell carcinoma. J Cancer. 8:523–530.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hou J, Zhou Y, Zheng Y, Fan J, Zhou W, Ng
IO, Sun H, Qin L, Qiu S, Lee JM, et al: Hepatic RIG-I predicts
survival and interferon-α therapeutic response in hepatocellular
carcinoma. Cancer Cell. 25:49–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen
Z, Fan J, Zhou W, Qiu S, Zhang Y, et al: Tumor-induced generation
of splenic erythroblast-like Ter-cells promotes tumor progression.
Cell. 173:634–648.e12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang F, Lu J, Peng X, Wang J, Liu X, Chen
X, Jiang Y, Li X and Zhang B: Integrated analysis of microRNA
regulatory network in nasopharyngeal carcinoma with deep
sequencing. J Exp Clin Cancer Res. 35:172016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X,
Yang T, Yang YX, Wang D, Qiu JX and Zhou SF: Plumbagin induces G2/M
arrest, apoptosis, and autophagy via p38 MAPK- and
PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell
carcinoma cells. Drug Des Devel Ther. 9:1601–1626. 2015.PubMed/NCBI
|
|
32
|
Bhayadia R, Krowiorz K, Haetscher N,
Jammal R, Emmrich S, Obulkasim A, Fiedler J, Schwarzer A, Rouhi A,
Heuser M, et al: Endogenous tumor suppressor microRNA-193b:
Therapeutic and prognostic value in acute myeloid leukemia. J Clin
Oncol. 36:1007–1016. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G
and Sun B: LINC00152 promotes proliferation in hepatocellular
carcinoma by targeting EpCAM via the mTOR signaling pathway.
Oncotarget. 6:42813–42824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yue B, Cai D, Liu C, Fang C and Yan D:
Linc00152 functions as a competing endogenous RNA to confer
oxaliplatin resistance and holds prognostic values in colon cancer.
Mol Ther. 24:2064–2077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang J, Qin J and Su Y: miR-193b-3p
possesses anti-tumor activity in ovarian carcinoma cells by
targeting p21-activated kinase 3. Biomed Pharmacother.
96:1275–1282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mets E, Van der Meulen J, Van Peer G,
Boice M, Mestdagh P, Van de Walle I, Lammens T, Goossens S, De
Moerloose B, Benoit Y, et al: MicroRNA-193b-3p acts as a tumor
suppressor by targeting the MYB oncogene in T-cell acute
lymphoblastic leukemia. Leukemia. 29:798–806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen QN, Chen X, Chen ZY, Nie FQ, Wei CC,
Ma HW, Wan L, Yan S, Ren SN and Wang ZX: Long intergenic non-coding
RNA 00152 promotes lung adenocarcinoma proliferation via
interacting with EZH2 and repressing IL24 expression. Mol Cancer.
16:172017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Y, Liu J, Bai H, Dang Y, Lv P and Wu
S: Long intergenic non-coding RNA 00152 promotes renal cell
carcinoma progression by epigenetically suppressing P16 and
negatively regulates miR-205. Am J Cancer Res. 7:312–322.
2017.PubMed/NCBI
|
|
41
|
Lenarduzzi M, Hui AB, Alajez NM, Shi W,
Williams J, Yue S, O'Sullivan B and Liu FF: MicroRNA-193b enhances
tumor progression via down regulation of neurofibromin 1. PLoS One.
8:e537652013. View Article : Google Scholar : PubMed/NCBI
|
